SEC Outlines What’s Next On JOBS Act
Executive Summary
While some aspects of the JOBS Act are up and running, many aren’t. At its annual meeting on capital formation for small business, SEC took the time to consider the remaining parts of the law that await rule making and to think beyond JOBS to other potential changes.
You may also be interested in...
Biotech Equity Crowdfunding Gets A Head Start Overseas
Can crowdfunding fill the biotech capital gap? In the US, new services are jockeying at the starting gate even though the government’s final rules won’t be ready soon, while in Europe the experiment has begun in earnest.
JOBS Gets To Work On IPOs, Companies Cherry Pick Benefits
The JOBS Act has made it easier for life sciences companies to file to go public and to communicate with potential investors. But the cost savings from reduced regulatory compliance has yet to be fully achieved.
Social Norms Shift, But U.S. Rules On Cannabis-Related Drug R&D Lag Behind
While public, regulatory and law enforcement attitudes toward marijuana in the U.S. continue to shift, it’s still tough to pursue legitimate clinical research on cannabis and cannabinoids. Could the exceptions slowly become the rule?